FOXP3 and acute myeloid leukemia: Our previous study revealed that the co-inhibitory TIGIT axis may be involved in the regulation of Foxp3+ γδ Treg cells and indicate the clinical progression and prognosis of AML patients with different clinical statuses (48, 49).